Immunai News and Activities

Immunai is one of the...

• TOB Iconic 10,000;
• Unicorn.

View the org chart displaying its 16 main executives

Most searched biographies at Immunai

• Noam Solomon, Chief Executive Officer
• Evan Zisholtz, Vice President, Corporate Development
• Ronit Weinstein, Vice President, Human Resources

Create your alert
to follow the executive moves at Immunai.

Immunai has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Immunai

• Immunai Announces Agreement to advance an Inflammatory Bowel Disease Target with AstraZeneca
• Immunai and Teva launch multi-tear AI collaboration for smarter drug development | CTech
• Immunai announces collaboration with AstraZeneca for advanced clinical trial optimization
• Improving drug development with a vast map of the immune system
• Newsroom - Immunai
• News - Immunai
• Press Releases - Immunai
• Newsroom - Immunai
• https://www.immunai.com/press/immunology-and-machine-learning-online-symposium
• Immunai Raises $215 Million to Accelerate Development of Its Immune-First Drug Actuary Platform
• View more press releases Close

Social media about Immunai

• Immunai on Wikipedia, Google News & Yahoo Finance
• Immunai on LinkedIn, X (Twitter) & YouTube